Screener
Aquestive Therapeutics, Inc. AQST Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
FAQ
- What is Aquestive Therapeutics, Inc.'s gross profit?
- Aquestive Therapeutics, Inc. (AQST) reported gross profit of $9.8M in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s gross profit changed year-over-year?
- Aquestive Therapeutics, Inc.'s gross profit increased by 80.1% year-over-year, from $5.44M to $9.8M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s gross profit?
- Over 3 years (2022 to 2025), Aquestive Therapeutics, Inc.'s gross profit has grown at a -2.8% compound annual growth rate (CAGR), from $28.29M to $25.99M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Aquestive Therapeutics, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude